Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

A first-in-human peptide vaccine targeting H3K27M; encouraging early findings in 8 adults with diffuse midline glioma.

Neuro-oncology - 5 Jan 2024

Hotchkiss Kelly M, Cho Eugene J, Khasraw Mustafa

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Brain Neoplasms
Share to Glioma
Share to Mutation

Source

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Open in PubMed Open full text

Identifiers

PMID: 37930280
DOI: 10.1093/neuonc/noad203
PMCID: PMC10768979

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

A first-in-human peptide vaccine targeting H3K27M; encouraging early findings in 8 adults with diffuse midline glioma.PMID 37930280Read ↗

A H3K27M-targeted vaccine in adults with diffuse midline glioma.Semantic proximity Read ↗

INTERCEPT H3: a multicenter phase I peptide vaccine trial for the treatment of H3-mutated diffuse midline gliomasSemantic proximity Read ↗

Neoepitope-specific vaccination of a patient with diffuse midline glioma targeting H3K27M induces polyclonal B and T cell responses across diverse HLA allelesSemantic proximity Read ↗

H3K27M neoepitope vaccination in diffuse midline glioma induces B and T cell responses across diverse HLA loci of a recovered patientSemantic proximity Read ↗

H3K27M Mutation Reshapes the Antigenic Landscape in Diffuse Midline GliomaSemantic proximity Read ↗

K27M-mutant histone-3 as a novel target for glioma immunotherapySemantic proximity Read ↗

H3 K27M-altered glioma and diffuse intrinsic pontine glioma: Semi-systematic review of treatment landscape and future directions.Semantic proximity Read ↗

H3.3K27M mutation is not a suitable target for immunotherapy in HLA-A2+ patients with diffuse midline glioma.Semantic proximity Read ↗

A Specific Peptide Vaccine Against IDH1(R132H) Glioma.Semantic proximity Read ↗

Novel and shared neoantigen derived from histone 3 variant H3.3K27M mutation for glioma T cell therapy.Semantic proximity Read ↗

GD2-CAR T cell therapy for H3K27M-mutated diffuse midline gliomas.Semantic proximity Read ↗

A road map for the treatment of pediatric diffuse midline glioma.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.